Overview

A Study to Compare Efficacy and Safety of Trifarotene Cream When Used With an Oral Antibiotic for the Treatment of Severe Acne Vulgaris (AV)

Status:
Completed

Trial end date:
2021-08-30

Target enrollment:

Participant gender:

Summary

The purpose of this study is to demonstrate that daily use of topical trifarotene (CD5789) 50 microgram per gram (mcg/g) cream when used in association with oral antibiotic is safe and effective for the treatment of severe AV.

Phase:

Phase 4

Details

Lead Sponsor:

Galderma R&D

Treatments:

Doxycycline
Trifarotene